Wyeth-Ayerst Prempro/Premphase single tablets will replace current products in early 1996.
Executive Summary
WYETH-AYERST PREMPRO/PREMPHASE SINGLE-TABLET FORMULATION for hormone replacement therapy will be launched in the first quarter of 1996. The single-tablet version of the combination conjugated estrogens and medroxyprogesterone product cleared FDA on Nov. 17. Data from several trials show that when progestin is added to estrogen therapy the risk of uterine cancer in nonhysterectomized women is reduced.